Latest Articles

Publication Date
All News Scientific
Diagnostic Accuracy of Endometrial Sampling Methods for Determining Histologic Type and Grade in Endometrial Cancer: A Retrospective Cohort Study - Cureus

Diagnostic Accuracy of Endometrial Sampling Methods for Determining Histologic Type and Grade in Endometrial Cancer: A Retrospective Cohort Study Cureus

Published: Oct. 26, 2025, 10:10 a.m.
Read Full Article
Researchers identify common painkiller that may prevent endometrial cancer - Daily Nation

Researchers identify common painkiller that may prevent endometrial cancer Daily Nation

Published: Oct. 26, 2025, 10 a.m.
Read Full Article
Research progress and potential therapeutic targets of a novel disulfide stress-driven cell death-disulfidptosis in gynecological tumors and other gynecological disorders.

Disulfidptosis is a novel Nicotinamide Adenine Dinucleotide Phosphate (NADPH) deficiency-driven cell death pathway characterized by cystine overload and aberrant disulfide bond formation in actin cytoskeletal proteins, distinct from apoptosis, ferroptosis, …

Published: Oct. 25, 2025, midnight
Read Full Article
Disulfidptosis SLC7A11 endometriosis gynecological cancers immune checkpoint
Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis - Cell Communication and Signaling

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis Cell Communication and Signaling

Published: Oct. 24, 2025, 12:50 p.m.
Read Full Article
WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer - OncLive

WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer OncLive

Published: Oct. 23, 2025, 6:03 p.m.
Read Full Article
Endometrial Cancer and Body Image: How to Cope and Rebuild Confidence - Everyday Health

Endometrial Cancer and Body Image: How to Cope and Rebuild Confidence Everyday Health

Published: Oct. 22, 2025, 7:12 p.m.
Read Full Article
Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer - Targeted Oncology

Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer Targeted Oncology

Published: Oct. 22, 2025, 6:21 p.m.
Read Full Article
Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial - Targeted Oncology

Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial Targeted Oncology

Published: Oct. 22, 2025, 5:11 p.m.
Read Full Article
KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer - Indian Pharma Post

KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer Indian Pharma Post

Published: Oct. 22, 2025, 5:03 p.m.
Read Full Article
Nearly half of endometrial cancer patients respond to Rina-S in trial - Rare Cancer News

Nearly half of endometrial cancer patients respond to Rina-S in trial Rare Cancer News

Published: Oct. 22, 2025, 1:31 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!